These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21668965)

  • 1. Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention.
    Yiu KH; Pong V; Siu CW; Lau CP; Tse HF
    Cardiovasc Diabetol; 2011 Jun; 10():52. PubMed ID: 21668965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk diabetic patients with unprotected left main coronary artery disease: characteristics and medium-term outcomes of percutaneous revascularization with drug-eluting stents.
    Fernández JF; González CS; Navarro MJ; Fernández Guerrero JC; Menchero AG; Briales JH; Piris RM; Herrador J; Herrera MG; García JM
    Tex Heart Inst J; 2011; 38(4):386-91. PubMed ID: 21841866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.
    Gach O; Louis O; Chapelle JP; Vanbelle S; Pierard LA; Legrand V
    Heart Vessels; 2009 Jul; 24(4):267-70. PubMed ID: 19626398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stenting in diabetic patients: the disease above all.
    Belardi JA
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):915-6. PubMed ID: 19016468
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
    Lai J; Wu B; Sun J; Shang Y; Zhu J
    Coron Artery Dis; 2013 Nov; 24(7):566-71. PubMed ID: 23994882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.
    Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
    J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients.
    Jeong HS; Cho JY; Kim EJ; Yu CW; Ahn CM; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2013 Dec; 24(8):676-83. PubMed ID: 23994881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases.
    Ikemoto T; Hojo Y; Kondo H; Takahashi N; Hirose M; Nishimura Y; Katsuki T; Shimada K; Kario K
    Heart Vessels; 2012 Jul; 27(4):344-51. PubMed ID: 21667051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
    J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention.
    El Ghannudi S; Ohlmann P; Jesel L; Radulescu B; El Adraa E; Crimizade U; Wiesel ML; Gachet C; Morel O
    Atherosclerosis; 2011 Aug; 217(2):465-72. PubMed ID: 21524751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.